FDA Adverse Event Malfunction Summary report: N

OEM EST 18FR 400 SERIES 100CS

MDR report key: 4359855 · Received December 12, 2014

Report

Report Number
9613793-2014-00010
Event Type
Malfunction
Date Received
December 12, 2014
Date of Event
November 3, 2014
Report Date
December 12, 2014
Manufacturer
DEROYAL CIENTIFICA DE LATINOAMERICA SA GLOBLA PARK
Product Code
BZT
PMA / PMN Number
K925789
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

NO FURTHER INFORMATION IS AVAILABLE AT THIS TIME. WILL PROVIDE FOLLOW UPS IF INFORMATION BECOMES AVAILABLE.

Description of Event or Problem · 1

TEMPERATURE PROBES ARE NOT READING PROPERLY. ESOPHAGEAL STETHOSCOPES. VITAL TEMP 18FR REF 1011EU LOT 9475716. THE FIRST FAILURE OCCURRED WHEN I PLACED THE ES, THEN HOOKED UP THE MONITOR LEAD AND GOT DOUBLE DASHES, I.E. NO READING. I DID SOME TROUBLESHOOTING THAT INDICATED THAT THE LEAD WIRE AND THE MONITOR WERE OK. I DECIDED IT MUST HAVE BEEN AN ISOLATED DEFECT, BECAUSE I HADN'T SEEN IT BEFORE, BUT DECIDED TO CHECK THE PROBES AT ROOM TEMPERATURE PRIOR TO INSERTING WHAT MIGHT BE A USELESS MONITOR INTO SOMEONE'S ESOPHAGUS. THERE'S A SMALL BUT NON-ZERO RISK OF COMPLICATIONS FROM INSERTING EVEN A FUNCTIONING ES INTO A PATIENT. I OPENED THIS PACKAGE AND TESTED THE PROBE. IT READ ROOM TEMPERATURE CORRECTLY, SO I INSERTED THE ES INTO MY PATIENT. AT FIRST, THE PROBE GAVE CREDIBLE READINGS IN THE 35-367 C RANGE. SUDDENLY THE TEMPERATURE BEGAN TO VACILLATE ALL OVER THE PLACE, READING ANYWHERE FROM 19 TO 36 C. THIS WAS NOT ASSOCIATED WITH CAUTERY OR ANY OTHER "NORMAL" SOURCE OF INTERFERENCE. I CANNOT RULE OUT PENETRATION OF THE LIQUID-PROOF BARRIER TO THE ES AT THIS TIME, WHICH MIGHT EXPOSE THE PATIENT TO STRAY CURRENTS INDUCED IN THE LEAD WIRE OR A SPURIOUS PATH TO GROUND IN THE CAUTERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
815437 OEM EST 18FR 400 SERIES 100CS STETHOSCOPE, ESOPHAGEAL, WITH ELECTR BZT DEROYAL CIENTIFICA DE LATINOAMERICA SA GLOBLA PARK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention